Clinical trials document that semaglutide users lose approximately 510 pounds by the end of month 1 as appetite suppression activates and caloric intake decreases
In one of the most comprehensive approaches, a meta-analysis of 39 prospective cohort studies comprising over 15 million individuals suggested that an intake of up to 500 mg/d of total flavonoids was associated with a 27 %, 20 % and 23 % lower relative risk (RR) of cardiovascular disease (CVD), stroke and coronary heart disease (CHD), respectively (Reference Micek, Godos and Del Rio6)
Potential Withdrawal Symptoms Discontinuing tirzepatide can result in withdrawal symptoms due to its effects on blood sugar regulation and appetite control
Today, defining clear and Read More GLP-1 Dose Escalation in 2026: High-Dose Era
A healthcare provider may recommend it for arthritis, psoriasis, eczema, or hormonal imbalance
+ Strict Clean-Label: 100% plant-based, allergen-free, and non-GMO